NCT02620813View on ClinicalTrials.gov

De Novo Lipogenesis of Sebaceous Glands in Acne

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 12, 2017

Study Completion Date

October 12, 2017

Conditions
Acne Vulgaris
Interventions
DRUG

Tretinoin

Subjects will apply 0.5% tretinoin cream nightly to their face for a total of 12 weeks.

DRUG

Isotretinoin

Subjects will take isotretinoin as prescribed by their dermatologist.

Trial Locations (2)

95616

Dermatology Research Area, Davis

95816

UC Davis Department of Dermatology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02620813 - De Novo Lipogenesis of Sebaceous Glands in Acne | Biotech Hunter | Biotech Hunter